Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?

Exide's 100% stake in ING Vysya to strain core ops: Edelweiss Securities

In near term, the business would require significant financial, strategic support, which may impact Exide till a new partner is roped in

Related News

Exide Industries' decision to buy out the partner stake in its insurance joint venture ING Vysya Life Insurance will strain its core operations, said a report by Edelweiss Securities. The company had yesterday said that it would increase its stake in the life insurance company to 100% by paying Rs 550 crore for the remaining 50% stake from the other partners including ING.

In a note to its clients, Edelweiss Securities said that they have valued the life insurance company at 1.6X embedded value, whereas its peers are in the valuation range of 1.5-2X. It It added that since the transaction has been in-principle agreed upon at 1X embedded value, it is an attractive transaction for Exide.

However, it added that in the near term, the business would require significant financial and strategic support, which may impact Exide till a new partner is roped in. "The exit of ING/partners will lay the onus of supporting and running the business till such time a strategic partner is roped in. This can drag down the company's performance in the near term," Edelweiss Securities said in the note.

The brokerage said that while the exit of ING from the JV was long due and is positive post induction of a strategic partner, it added that the operations of the life insurance firm will require strategic and financial support till then. This commitment from Exide, according to the note, would strain its resources and managerial bandwidth. The brokerage has said that they maintain 'HOLD' for Exide with a target price of Rs 132.

Meanwhile, a report by Citi has downgraded Exide to sell, on account of its ING Vysya acquisition which is unrelated to core business. Citi said that the de-rating is due to the fact that this acquisition is completely unrelated, loss-making and could possibly require incremental funding, and is unlikely to find a purchaser. It added that they view it negatively and expect the stock to de-rate on the back of this event.

At 12.45 pm, the shares of Exide Industries traded at Rs 123.40 on the Bombay Stock Exchange, down 1.2% from previous day's close.

Read More

Suzlon, Tanti, 4 company execs settle charges with Sebi

After they together paid Rs 12 lakh to settle charges related to alleged delay in amending insider trading norms

Back to Top

Quick Links

Back to Top